We have reported that blood interleukin-6 (IL 6) and interleukin-8 (IL 8) are increased in diabetes ketoacidosis. Recently, hepatocyte growth factor (HGF) has been structurally analyzed as a factor in promoting regeneration of the liver. HGF was also resolved to be cytokine with various functions.
We considered the potential of blood HGF increase in diabetic ketoacidosis and blood HGF for ketoacidosis patients. HGF of hyperglycemia patients not presenting ketosis in their serum was measured as a control.
HGF of 12 hospitalized diabetic ketoacidosis patients and 8 hyperglycemia patients was measured from frozen stored serum 6, 12, 24, and 48 hours after insulin treatment using enzyme immunoassay (EIA).
HGF of 12 hospitalized diabetic ketoacidosis patients, was 1.29±0.99ng/m
l on admission, significantly higher (p<0.05) than HGF of hyperglycemia patients at 0.35±0.15ng/m
l. HGF in the serum of ketoacidosis patients 6, 12, and 24 hours after insulin treatment was also significantly higher (p<0.05) than HGF of hyperglycemia patients. HGF gradually decreased after ketoacidosis treatment, compared to HGF from the serum of hyperglycemia patients where there was no significant difference between admission and 6, 12, 24, and 48 hours after treatment.
High HGF was detected in the serum of 12 diabetes ketoacidosis patients on admission. Considering that HGF of hyperglycemia patients was 0.39 or under, which is normal, we suppose that ketoacidosis increased blood HGF. Although the mechanism of this increase HGF is not clear, acute failure of metabolism produces HGF from endothelial cells.
View full abstract